Posts by: Alice Melão

News

Enrollment has been completed in an ongoing Phase 3 clinical trial assessing the safety and efficacy of experimental therapy lenabasum in patients with systemic sclerosis (SSc). Corbus Pharmaceuticals, lenabasum’s ... Read more

April 26, 2019April 26, 2019

Corbus Changes Goal of Phase 3 Lenabasum Trial in Diffuse Cutaneous SSc, Sees as Step to Possible ‘Success’

News

Corbus Pharmaceuticals is adjusting the primary efficacy outcome of the ongoing and global RESOLVE-1 Phase 3 trial of lenabasum as a possible treatment for diffuse cutaneous systemic sclerosis (SSc). The change ... Read more

April 24, 2019April 24, 2019

DEA Clears Cannabinoid-derived Active Ingredient in Investigational Scleroderma Therapy EHP-101

News

The U.S. Drug Enforcement Administration (DEA) has cleared the use of the active ingredient in EHP-101, an investigational therapy for treating multiple sclerosis (MS) and systemic sclerosis (SSc), according to Emerald Health ... Read more

March 12, 2019March 12, 2019

First Patient Dosed in Ongoing Trial to Test AVID200 for Diffuse Cutaneous Systemic Sclerosis

News

The first patient with diffuse cutaneous systemic sclerosis (SSc) has been given the investigational therapy AVID200 in an ongoing Phase 1b trial, announced the therapy’s developer Forbius. The open-label study ... Read more

February 19, 2019February 19, 2019

Systemic Sclerosis Patients Have Deregulated Levels of Skin Microorganisms, Study Shows

News

Deregulation of the microorganisms that naturally populate the skin is associated with increased inflammation and disease duration in patients with systemic sclerosis, a study shows. The study, “Microbiome dysbiosis ... Read more

December 18, 2018December 18, 2018

SSc Patients at Risk of Developing Wrist Nerve Damage, Study Suggests

News

People with systemic sclerosis (SSc) are at higher risk for degeneration of a main wrist nerve, a study suggests. Although for many people this condition might be asymptomatic, early ... Read more

November 8, 2018November 8, 2018

Men at Risk of More Severe and Active Scleroderma at Disease Onset, EUSTAR Study Shows

News

Men are at greater risk of more severe and active systemic sclerosis (SSc) than are women at early stages of the disease, a large review study shows. The study, ... Read more

November 1, 2018November 1, 2018

New Computer-based Analysis Method Identifies Scleroderma Patients Who May Benefit Most from Stem Cell Transplant

News

The analysis of gene profile in blood samples may help identify scleroderma patients who could benefit most from stem cell transplant, a research study suggests. The study findings were ... Read more

October 4, 2018October 4, 2018

Raynaud’s Association Campaign Aims to Raise Awareness About Disease’s Pain

News

“Don’t Turn a Cold Shoulder to Painful Fingers” is the new campaign launched by the Raynaud’s Association to raise awareness about the pain experienced by those affected by Raynaud’s ... Read more

September 18, 2018September 18, 2018

Increased Skin Pigmentation Lesions May Help Predict Course of Systemic Sclerosis, Study Suggests

News

Evaluating changes in skin pigmentation could be useful for the management of systemic sclerosis (SSc) patients, particularly to identify those at risk of developing digital ulcers, researchers suggest. This ... Read more

Posts by: Alice Melão

Alice Melão

Enrollment Complete in Phase 3 Trial Testing Lenabasum in Diffuse Cutaneous SSc Patients

Corbus Changes Goal of Phase 3 Lenabasum Trial in Diffuse Cutaneous SSc, Sees as Step to Possible ‘Success’

DEA Clears Cannabinoid-derived Active Ingredient in Investigational Scleroderma Therapy EHP-101

First Patient Dosed in Ongoing Trial to Test AVID200 for Diffuse Cutaneous Systemic Sclerosis

Systemic Sclerosis Patients Have Deregulated Levels of Skin Microorganisms, Study Shows

SSc Patients at Risk of Developing Wrist Nerve Damage, Study Suggests

Men at Risk of More Severe and Active Scleroderma at Disease Onset, EUSTAR Study Shows

New Computer-based Analysis Method Identifies Scleroderma Patients Who May Benefit Most from Stem Cell Transplant

Raynaud’s Association Campaign Aims to Raise Awareness About Disease’s Pain

Increased Skin Pigmentation Lesions May Help Predict Course of Systemic Sclerosis, Study Suggests

Pin It on Pinterest